The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patterns of local-regional relapse after complete response by definitive chemoradiotherapy for stage II/III (non–T4) esophageal squamous cell carcinoma.
 
Kazuki Sudo
No Relationships to Disclose
 
Ken Kato
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Dainippon Sumitomo Pharma; Nippon Kayaku; Pfizer; Sanofi; Taiho Pharmaceutical
Research Funding - Daiichi Sankyo; Merck Serono; Ono Pharmaceutical
 
Hiroki Kuwabara
No Relationships to Disclose
 
Yusuke Sasaki
No Relationships to Disclose
 
Naoki Takahashi
No Relationships to Disclose
 
Hirokazu Shoji
No Relationships to Disclose
 
Satoru Iwasa
Honoraria - Chugai Pharma; Takeda
 
Yoshitaka Honma
No Relationships to Disclose
 
Natsuko T. Okita
Patents, Royalties, Other Intellectual Property - Novartis (Inst); Teijin Pharma (Inst)
 
Atsuo Takashima
Honoraria - Chugai Pharma
 
Tetsuya Hamaguchi
Consulting or Advisory Role - Chugai Pharma; Kyowa Hakko Kirin; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Research Funding - Dainippon Sumitomo Pharma; NanoCarrier
 
Yasuhide Yamada
Honoraria - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Dainippon Sumitomo Pharma; Novartis; Pfizer; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Merck Serono; Novartis; Otsuka; Taiho Pharmaceutical
 
Narikazu Boku
Honoraria - Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Shionogi
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)